Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
39.87 USD | 0.00% | +9.08% | -21.19% |
06-06 | Transcript : Ionis Pharmaceuticals, Inc. - Special Call | |
05-31 | Ionis Reports 'Positive Results' From Studies of Investigational Treatment for Hereditary Angioedema | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.19% | 5.81B | |
+55.55% | 59.28B | |
+43.17% | 40.94B | |
-4.71% | 40.17B | |
-5.56% | 28.69B | |
+13.76% | 26.63B | |
-22.00% | 18.89B | |
+31.50% | 12.46B | |
+2.16% | 12.42B | |
+25.70% | 12.26B |
- Stock Market
- Equities
- IONS Stock
- News Ionis Pharmaceuticals, Inc.
- Ionis Pharmaceuticals Insider Sold Shares Worth $5,938,129, According to a Recent SEC Filing